Chiara Orlandi, M.S., Ph.D.
About Chiara Orlandi, M.S., Ph.D.
Chiara Orlandi, M.S., Ph.D. is a Senior Scientist at Biotheryx, Inc. in San Diego, California, specializing in cell therapy research with a focus on NK cells, macrophages, and T cells.
Work at Biotheryx
Chiara Orlandi serves as a Senior Scientist at Biotheryx, Inc., a position she has held since 2022. Based in San Diego, California, she is involved in advancing research in cell therapy, particularly focusing on natural killer (NK) cells, macrophages, and T cells. Her role includes leading multidisciplinary projects and collaborating with various teams to drive innovation in therapeutic developments.
Education and Expertise
Chiara Orlandi has a robust academic background in biological sciences. She earned her Bachelor's degree in Biological and Biomedical Sciences from Università degli Studi dell'Insubria from 2000 to 2003. She continued her studies at the same institution, obtaining a Master's degree in Cell/Cellular and Molecular Biology from 2003 to 2005. Orlandi completed her PhD in Experimental Medicine and Oncology at Università degli Studi dell'Insubria from 2006 to 2010, further solidifying her expertise in molecular and cellular biology.
Background
Before joining Biotheryx, Chiara Orlandi accumulated extensive experience in various research roles. She worked as a Research Fellow at both Università degli Studi dell'Insubria and I.R.C.C.S. Ospedale Maggiore di Milano - Policlinico in 2005 and 2006. She later served as a Faculty member at the Institute of Human Virology, University of Maryland School of Medicine from 2017 to 2022, and as a Senior Research Scientist there from 2011 to 2017. Additionally, she held visiting scientist positions at Northwestern University and Duke University School of Medicine.
Achievements
Chiara Orlandi has led over 10 multidisciplinary projects focused on antibody discovery, fostering cross-functional collaborations. She secured a significant research grant totaling $18 million for preclinical and clinical studies. Orlandi has also contributed to the development of immunotherapeutic drugs and antibodies targeting infectious diseases and cancer. She has delivered more than 10 invited oral presentations at local and international conferences, sharing her insights on cell therapy.